50+ Key Biomedical Databases from UMLS, NCI, COSMIC and more
The Power of TheraKey™ Quality Knowledge Database
800+ Cancer Related Genes
One of the Most Comprehensive Quality Database for Oncology
260,000+ Worldwide Clinical Trials from clinicaltrials.gov
Expanding Treatment Options from Curated Database and Report
2,000 FDA Approved and Investigational Cancer Drugs
Reporting Targeted Therapies with TheraKey™ Interpretation Report
Variant Classification
Based on guidelines recommended by AMP, ASCO and CAP
Tumor Mutational Burden (TMB) Calculation
To aid in prediction of responses to immunotherapies
Clinical Reporting for Fusion Genes
Therapeutic options and matched clinical trials
Vela Genomics for Powerful Next-Generation Sequencing (NGS) Clinical Reporting
Accurate
Advanced
Fast
ConclusiveTheraKey™ by Vela Genomics provides Accurate Clinical Interpretation and Reporting for high-throughput NGS somatic oncology testing. The powerful solution transforms rich genomics profiling data into clinically actionable outcomes. TheraKey™ is compatible with any NGS instrument to provide information beyond the standard reporting. It saves costs and accelerate TAT by saving time spent on manually researching and cross referencing all information from various database. We aim to assist clinicians in expanding their cancer patient’s treatment options, empowering precision medicine in healthcare.
Learn More About TheraKey™TheraKey™ Interpretation Report for Accurate Matching of Patient-to-Treatments
FDA Approved, Off-Label, Investigational Drugs Contraindicated Therapies by NCCN Guidelines® Matched Recruiting Clinical Trials Worldwide Reviewed by Certified Clinicians and Curation Scientists
